LIPF and obesity disorder: The famous anti-obesity drug orlistat is known as the hydrogenated form of lipstatin, which prevents hydrolysis of triglycerides by inhibiting the activities of pancreatic and gastric lipases, thereby reducing their absorption and the amount of free fatty acids and monoglycerides in the intestine.30